VISKA Bio is an early-stage immunotherapy platform located in LabCentral, the premier shared lab facility for life science startups in the world. Their focus is on engaging localized immunogenic cell death to treat and prevent cancer. Their slogan, "Engaging localized immunogenic cell death in cancer therapy," encapsulates their mission succinctly. Specializing in the Biotechnology industry, VISKA Bio demonstrates tremendous potential in the fight against cancer.
There is no investment information
No recent news or press coverage available for VISKA Bio.